---
document_datetime: 2023-09-21 20:16:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rekambys-epar-all-authorised-presentations_en.pdf
document_name: rekambys-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8083219
conversion_datetime: 2025-12-18 11:29:11.70937
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                         | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                      |
|------------------|-------------------|------------|---------------------------------------------|---------------------------|-----------------------|---------------------------|------------------------------------------------|
| EU/1/20/1482/001 | REKAMBYS          | 600 mg     | Prolonged- release suspension for injection | Intramuscular use         | vial (glass)          | 2 ml (300 mg/ml)          | 1 vial + 1 syringe + 1 vial adaptor + 1 needle |
| EU/1/20/1482/002 | REKAMBYS          | 900 mg     | Prolonged- release suspension for injection | Intramuscular use         | vial (glass)          | 3 ml (300 mg/ml)          | 1 vial + 1 syringe + 1 vial adaptor + 1 needle |